Langar Global HealthTech ETF

LGHT
ETF Ticker

+12.08%

+11.48%

NYSE Arca Exchange

Equity

Global

Thematic

The Langar Global HealthTech ETF, LGHT_US, is an actively managed strategy providing exposure to Global, Thematic Equity. It is listed on the NYSE Arca Exchange and has assets under management of $2.3m (as of Aug 31, 2026). The ETF trades in USD and was listed on the exchange on Jan 10, 2024. It has a net expense ratio of 85bps. (All data in USD as of Oct 15, 2026 unless stated.)

The investment strategy guiding the actively managed Langar Global HealthTech ETF seeks long-term capital growth by investing ≥80% of net assets in exchange-listed equity of U.S. and developed-market HealthTech companies and ADRs, across capitalizations. The adviser first classifies HealthTech businesses by subsector (e.g., access to care, AI-enabled biopharma, clinical trials, decision support, hospital operations, insurance, treatment devices), then applies a proprietary Langar Rating to assess financial strength, governance/culture, controversies and vice exclusions. A HealthTech Industry Risk Score evaluates revenue, innovation/IP, standard-of-care and policy risks; weights incorporate market cap and revenue growth to emphasize higher growth potential. An investment committee reviews candidates; the portfolio is non-diversified and concentrated in the healthcare industry. Rebalancing occurs at least quarterly to add, resize or remove positions; securities may be sold anytime if fundamentals or strategic decisions impair long-term growth.

ETF Details

Key Facts

Issuer:
Langar
AUM:
$2.3m (as of Aug 31, 2026)
Net Expense Ratio:
85 bps
Inception Date:
Jan 10, 2024
Index:
Actively managed strategy
Dividend Frequency:
N/A

Trading

Ticker:
LGHT
Exchange:
NYSE Arca Exchange
ISIN:
US84858T8633
Trading Currency:
USD
Domicile:
United States

Classification & Risk

Asset Class:
Equity
Asset Region:
Global
Theme:
Thematic
Economic Development:
Global Markets
1 Year Volatility:
26.18%
3 Year Volatility:
N/A
5 Year Volatility:
N/A

Performance

TTM Dividend Yield:
0.00% (verify with issuer)
1 Month Performance:
13.30%
3 Month Performance:
29.44%
6 Month Performance:
25.10%
1 Year Performance:
11.48%
3 Year Performance:
N/A
5 Year Performance:
N/A
Investment Proposition

Langar Global HealthTech ETF (LGHT) targets the convergence of healthcare and technology by investing in companies advancing medical devices, diagnostics, digital health platforms, life-science tools, and healthcare IT. The fund’s active mandate pursues long-term capital appreciation by identifying innovators improving clinical workflows, patient outcomes, and system efficiency, while maintaining global diversification across market-cap tiers. Return potential reflects exposure to secular trends—aging populations, productivity needs, data-driven care—offset by thematic concentration, regulatory pathways, reimbursement dynamics, and valuation sensitivity typical of growth-oriented healthcare technology. The portfolio may display a tilt toward quality growth and innovation factors, with cyclicality tied to R&D funding conditions, interest-rate levels affecting duration-like equities, and policy cycles shaping adoption. Roles include a thematic satellite for growth, factor completion toward innovation within a core equity mix, or a targeted sleeve for mandates emphasizing healthcare efficiency. Suitable investors include research-driven allocators building thematic buckets and multi-asset managers seeking diversified healthcare technology exposure. A key risk to monitor is thematic concentration—limited breadth can magnify regulatory or reimbursement shocks across holdings.

ETF Analytics

Fund Discovery

4 Suggestions